4/A//SEC Filing
Gresham Gwendolyn 4/A
Accession 0000950170-24-002886
CIK 0001958086other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 2:47 PM ET
Size
8.7 KB
Accession
0000950170-24-002886
Insider Transaction Report
Form 4/AAmended
Transactions
- Exercise/Conversion
Common Stock
2022-12-31+12,000→ 19,783 total - Tax Payment
Common Stock
2023-12-31$17.66/sh−5,775$101,987→ 23,960 total - Tax Payment
Common Stock
2022-12-31$20.27/sh−4,722$95,715→ 15,061 total
Footnotes (2)
- [F1]The original Form 4, filed on January 3, 2024, is being amended by this Form 4 amendment to correct an administrative error of the issuer, whereupon the number of shares withheld to satisfy tax withholding obligations upon vesting of certain restricted performance shares was misreported as 5,643 shares. The corrected transaction reflects an increase of 132 shares withheld by the issuer as a result such vesting and a corresponding reduction in the number of shares beneficially owned by the reporting person.
- [F2]The original Form 4, filed on January 4, 2023, is being amended by this Form 4 amendment solely to correct an administrative error in transaction codes used by the issuer, which misreported that 12,000 shares of Common Stock were Disposed of (D) when in fact such shares were Acquired (A) upon vesting of restricted performance shares on December 31, 2022, and subsequently, 4,722 shares of Common Stock were Acquired (A) when in fact such shares were Disposed of (D) to satisfy tax withholding obligations incident to such vesting. The number of shares beneficially owned by the reporting person remains the same after correcting for the error in transaction codes.
Documents
Issuer
Core Laboratories Inc. /DE/
CIK 0001958086
Entity typeother
Related Parties
1- filerCIK 0001842114
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 2:47 PM ET
- Size
- 8.7 KB